AFAM Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$2.48M Buy
25,181
+75
+0.3% +$6.93K 0.34% 98
2018
Q2
$2.15M Buy
25,106
+20
+0.1% +$1.67K 0.31% 108
2018
Q1
$2.01M Sell
25,086
-64
-0.3% -$5.28K 0.22% 143
2017
Q4
$2.03M Buy
25,150
+4,027
+19% +$323K 0.22% 144
2017
Q3
$1.64M Buy
21,123
+1,396
+7% +$116K 0.2% 148
2017
Q2
$1.75M Buy
19,727
+1,552
+9% +$131K 0.22% 139
2017
Q1
$1.46M Sell
18,175
-146
-0.8% -$11.4K 0.2% 145
2016
Q4
$1.3M Buy
18,321
+2,289
+14% +$180K 0.2% 142
2016
Q3
$1.39M Sell
16,032
-5,837
-27% -$509K 0.22% 136
2016
Q2
$1.9M Sell
21,869
-1,454
-6% -$118K 0.31% 115
2016
Q1
$1.75M Buy
23,323
+535
+2% +$40.3K 0.29% 125
2015
Q4
$1.75M Buy
22,788
+1,648
+8% +$124K 0.27% 116
2015
Q3
$1.42M Buy
21,140
+783
+4% +$57.7K 0.22% 119
2015
Q2
$1.51M Buy
20,357
+980
+5% +$74.9K 0.2% 123
2015
Q1
$1.51M Buy
19,377
+326
+2% +$24.7K 0.19% 121
2014
Q4
$1.38M Sell
19,051
-101
-0.5% -$7.02K 0.18% 121
2014
Q3
$1.19M Buy
19,152
+142
+0.7% +$9.03K 0.15% 122
2014
Q2
$1.21M Buy
19,010
+182
+1% +$11.1K 0.15% 131
2014
Q1
$1.16M Buy
18,828
+321
+2% +$18.7K 0.16% 130
2013
Q4
$1.06M Buy
18,507
+1,036
+6% +$58.7K 0.14% 123
2013
Q3
$930K Buy
17,471
+1,234
+8% +$66.4K 0.13% 121
2013
Q2
$836K Buy
+16,237
New +$803K 0.12% 127

Other funds holding MDT

AFAM Capital's MDT Position: Q3 2018 in Review

AFAM Capital increased its Medtronic (MDT) stake by 0.3% in Q3 2018, buying an estimated $6.93K and bringing the position to 25,181 shares worth $2.48M. The position accounts for 0.34% of the portfolio, ranked #98.

AFAM Capital first reported a position in MDT in Q2 2013 and has held it in 22 quarters since. 1,484 funds tracked by Wall St. Rank hold MDT as of Q3 2018.

  • AFAM Capital held 25,181 shares of Medtronic worth $2.48M as of Q3 2018.
  • AFAM Capital bought 75 Medtronic shares in Q3 2018, an estimated $6.93K.
  • Medtronic made up 0.34% of AFAM Capital's portfolio in Q3 2018, its #98 holding.
  • AFAM Capital first reported a position in Medtronic in Q2 2013 and has held it in 22 quarters since.
  • 1,484 funds tracked by Wall St. Rank held Medtronic as of Q3 2018.

Based on AFAM Capital's 13F filing for Q3 2018, filed 14 Nov 2018.